Skip to main content

Table 1 Demographic and clinical data of patients

From: Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis

 

Crohn’s disease

Ulcerative colitis

Arthritis (SpA)

Patients (Ν)

34

26

14

 Sex (M/F)

22/12

15/11

11/3

 Age (years)

  Median [range]

32.5 [18–61]

42.5 [23–70]

34.5 [23–65]

BMI

 Median [range]

23.2 [18–34]

25.7 [19–31]

24.9 [18–28]

Disease duration (years)

 Median [range]

2 [0.1–20]

3 [0.1–30]

4 [0.2–20]

Disease localization

 Small bowel

10

 

3

 Large bowel

8

26

2

 Small and large bowel

16

 

2

IBD activity

 Active

20

20

 Inactive

14

6

7

Arthritis

10

8

 

 Active

5

4

10

 Inactive

5

4

4

Medications

 ASA

24

25

3

 Corticosteroids

26

10

5

 AZA

13

5

0

 MTX

0

0

4

 Anti-TNF

17

1

4

Combi medication (%)

28 (82)

13 (50)

2 (14)

  1. SpA Seronegative spondyloarthritis, ASA aminosalicylates, AZA azathioprine, MTX methotrexate, Anti-TNF anti-tumor necrosis factor alpha treatment